Completed NA INTERVENTIONAL 3-arm NCT02442245

The Effect of XSurge Supplementation on Biomarkers and Performance From High Intensity Resistance Exercise

The Effect of XSurgeTM Supplementation on Biomarkers, Oxidative Stress, and Recovery From High Intensity Resistance Exercise

Sponsor: Kemin Foods LC

Conditions Exercise Performance Recovery

Interventions Control: No supplementation Placebo: Microcrystalline Cellulose XSurge

Updated 6 times since 2017 Last updated: Jan 29, 2018 Started: Feb 28, 2015 Primary completion: Feb 29, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02442245, this NA trial focuses on Exercise Performance Recovery and remains completed. Sponsored by Kemin Foods LC, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2018 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Feb 2018 [monthly]

Active Not Recruiting NA

First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kemin Foods LC

Data source: Kemin Foods LC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Orlando, United States